Dr Muy-Teck Teh received his Biomedical Science degree (B.Sc. Hons, 1996) and PhD in Molecular Physiology (2000) from King’s College London, UK. Following two postdoctoral trainings funded by Wellcome Trust and Cancer Research UK. He is currently a tenured Senior Lecturer (Associate Professor) in Head and Neck Cancer at the Barts & the London School of Medicine & Dentistry, Queen Mary University of London, leading a clinical translational research group investigating cancer biomarker discovery, molecular diagnostics, molecular reprogramming of adult epithelial stem cell renewal, differentiation, and senescence. Dr Teh was awarded “Molecule of the Year 2010” for his pioneering research on FOXM1 in human cancer initiation. Overall, he aims to translate basic science into clinical applications and towards personalised medicine based on a combination of patient’s genetic, epigenetic, exosomal and gene expression signatures. Dr Teh has published over 50 papers in high impact journals including Nature Genetics, Cancer Research, Journal of Cell Science, American Journal of Human Genetics, Molecular Cancer, Genes Chromosomes & Cancer and International Journal of Cancer. He is also on editorial boards of several reputed international peer-reviewed journals and acted as grant reviewers for various UK and EU funding bodies and charities. Dr Teh has international collaborators from USA, Norway, Switzerland, Sri Lanka, Malaysia and China on clinical translation of molecular diagnostics for quantitative cancer detection.

Transcriptomics, epigenomics, genomics, SNP, LOH, CNA, bioinformatics, reverse transcription quantitative real-time PCR (RT-qPCR), biomarker selection from omics big databases, clinical translational research, human primary cell culture, molecular biology, cloning, retroviral transduction, organotypic 3D cultures, exosome study, differential ultracentrifugation.